Balance Labs (BLNC) Amortization of Deferred Charges (2023 - 2024)

Balance Labs (BLNC) reported Amortization of Deferred Charges of -$2834.0 for Q4 2024, down 149.98% on a YoY basis from $5670.0 in Q1 2024, and down 200.0% quarter-over-quarter from $2834.0 in Q3 2024.

Balance Labs (BLNC) Amortization of Deferred Charges (2023 - 2024) Analysis & Trends

Balance Labs has reported Amortization of Deferred Charges for 2 years, with the latest figure at -$2834.0 in Q4 2024.

  • For the quarter ending Q4 2024, Amortization of Deferred Charges fell 149.98% year-over-year to -$2834.0; the trailing twelve-month figure through Sep 2024 stood at $8504.0 (changed N/A YoY), and the FY2023 full-year result was $8504.0, changed N/A from the prior year.
  • Amortization of Deferred Charges for Q4 2024 stood at -$2834.0, down from $2834.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $5670.0 in Q4 2023, with the low at -$2834.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Verisk Analytics 24.65 Bn 24.13 Bn 546.00 Mn
2 Equifax 20.23 Bn 20.17 Bn 881.80 Mn
3 Booz Allen Hamilton Holding 9.63 Bn 8.90 Bn 1.50 Bn
4 Fti Consulting 4.78 Bn 4.58 Bn 306.83 Mn
5 Huron Consulting 1.88 Bn 1.85 Bn 143.61 Mn
6 ICF International 1.30 Bn 1.25 Bn 166.86 Mn
7 Cra International 954.07 Mn 921.58 Mn 55.95 Mn
8 SBC Medical Group Holdings 308.99 Mn 159.92 Mn 28.93 Mn
9 Roma Green Finance 302.57 Mn 299.88 Mn -
10 Balance Labs - - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -2,834.00
Dec 31, 2024 -2,834.00
Sep 30, 2024 2,834.00
Sep 30, 2024 2,834.00
Jun 30, 2024 -2,834.00
Jun 30, 2024 -2,834.00
Mar 31, 2024 2,834.00
Mar 31, 2024 2,834.00
Dec 31, 2023 5,670.00
Dec 31, 2023 5,670.00